607 related articles for article (PubMed ID: 16385499)
1. Association between protein tyrosine phosphatase 22 variant R620W in conjunction with the HLA-DRB1 shared epitope and humoral autoimmunity to an immunodominant epitope of cartilage-specific type II collagen in early rheumatoid arthritis.
Burkhardt H; Hüffmeier U; Spriewald B; Böhm B; Rau R; Kallert S; Engström A; Holmdahl R; Reis A
Arthritis Rheum; 2006 Jan; 54(1):82-9. PubMed ID: 16385499
[TBL] [Abstract][Full Text] [Related]
2. Epitope-specific recognition of type II collagen by rheumatoid arthritis antibodies is shared with recognition by antibodies that are arthritogenic in collagen-induced arthritis in the mouse.
Burkhardt H; Koller T; Engström A; Nandakumar KS; Turnay J; Kraetsch HG; Kalden JR; Holmdahl R
Arthritis Rheum; 2002 Sep; 46(9):2339-48. PubMed ID: 12355481
[TBL] [Abstract][Full Text] [Related]
3. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles.
Snir O; Widhe M; von Spee C; Lindberg J; Padyukov L; Lundberg K; Engström A; Venables PJ; Lundeberg J; Holmdahl R; Klareskog L; Malmström V
Ann Rheum Dis; 2009 May; 68(5):736-43. PubMed ID: 18635594
[TBL] [Abstract][Full Text] [Related]
4. Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis.
Burkhardt H; Sehnert B; Bockermann R; Engström A; Kalden JR; Holmdahl R
Eur J Immunol; 2005 May; 35(5):1643-52. PubMed ID: 15832289
[TBL] [Abstract][Full Text] [Related]
5. The PTPN22 1858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden.
Kokkonen H; Johansson M; Innala L; Jidell E; Rantapää-Dahlqvist S
Arthritis Res Ther; 2007; 9(3):R56. PubMed ID: 17553139
[TBL] [Abstract][Full Text] [Related]
6. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.
Xue Y; Zhang J; Chen YM; Guan M; Zheng SG; Zou HJ
Scand J Rheumatol; 2008; 37(3):183-7. PubMed ID: 18465452
[TBL] [Abstract][Full Text] [Related]
7. PTPN22 polymorphism and anti-cyclic citrullinated peptide antibodies in combination strongly predicts future onset of rheumatoid arthritis and has a specificity of 100% for the disease.
Johansson M; Arlestig L; Hallmans G; Rantapää-Dahlqvist S
Arthritis Res Ther; 2006; 8(1):R19. PubMed ID: 16507117
[TBL] [Abstract][Full Text] [Related]
8. Auto-antibodies, HLA and PTPN22: susceptibility markers for rheumatoid arthritis.
Orozco G; Pascual-Salcedo D; López-Nevot MA; Cobo T; Cabezón A; Martín-Mola E; Balsa A; Martín J
Rheumatology (Oxford); 2008 Feb; 47(2):138-41. PubMed ID: 18156150
[TBL] [Abstract][Full Text] [Related]
9. Genetic background of anticyclic citrullinated peptide autoantibody production in Hungarian patients with rheumatoid arthritis.
Poór G; Nagy ZB; Schmidt Z; Brózik M; Merétey K; Gergely P
Ann N Y Acad Sci; 2007 Sep; 1110():23-32. PubMed ID: 17911417
[TBL] [Abstract][Full Text] [Related]
10. Contribution of PTPN22 1858T, TNFRII 196R and HLA-shared epitope alleles with rheumatoid factor and anti-citrullinated protein antibodies to very early rheumatoid arthritis diagnosis.
Goëb V; Dieudé P; Daveau R; Thomas-L'otellier M; Jouen F; Hau F; Boumier P; Tron F; Gilbert D; Fardellone P; Cornélis F; Le Loët X; Vittecoq O
Rheumatology (Oxford); 2008 Aug; 47(8):1208-12. PubMed ID: 18535030
[TBL] [Abstract][Full Text] [Related]
11. Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles.
Irigoyen P; Lee AT; Wener MH; Li W; Kern M; Batliwalla F; Lum RF; Massarotti E; Weisman M; Bombardier C; Remmers EF; Kastner DL; Seldin MF; Criswell LA; Gregersen PK
Arthritis Rheum; 2005 Dec; 52(12):3813-8. PubMed ID: 16320316
[TBL] [Abstract][Full Text] [Related]
12. The PTPN22 R620W polymorphism associates with RF positive rheumatoid arthritis in a dose-dependent manner but not with HLA-SE status.
Lee AT; Li W; Liew A; Bombardier C; Weisman M; Massarotti EM; Kent J; Wolfe F; Begovich AB; Gregersen PK
Genes Immun; 2005 Mar; 6(2):129-33. PubMed ID: 15674368
[TBL] [Abstract][Full Text] [Related]
13. Opposing effects of HLA-DRB1*13 alleles on the risk of developing anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis.
Lundström E; Källberg H; Smolnikova M; Ding B; Rönnelid J; Alfredsson L; Klareskog L; Padyukov L
Arthritis Rheum; 2009 Apr; 60(4):924-30. PubMed ID: 19333936
[TBL] [Abstract][Full Text] [Related]
14. Arthritogenic antibodies specific for a major type II collagen triple-helical epitope bind and destabilize cartilage independent of inflammation.
Nandakumar KS; Bajtner E; Hill L; Böhm B; Rowley MJ; Burkhardt H; Holmdahl R
Arthritis Rheum; 2008 Jan; 58(1):184-96. PubMed ID: 18163493
[TBL] [Abstract][Full Text] [Related]
15. Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins.
Huizinga TW; Amos CI; van der Helm-van Mil AH; Chen W; van Gaalen FA; Jawaheer D; Schreuder GM; Wener M; Breedveld FC; Ahmad N; Lum RF; de Vries RR; Gregersen PK; Toes RE; Criswell LA
Arthritis Rheum; 2005 Nov; 52(11):3433-8. PubMed ID: 16255021
[TBL] [Abstract][Full Text] [Related]
16. Associations between genetic factors, tobacco smoking and autoantibodies in familial and sporadic rheumatoid arthritis.
Michou L; Teixeira VH; Pierlot C; Lasbleiz S; Bardin T; Dieudé P; Prum B; Cornélis F; Petit-Teixeira E
Ann Rheum Dis; 2008 Apr; 67(4):466-70. PubMed ID: 17660221
[TBL] [Abstract][Full Text] [Related]
17. Predominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritis.
Bäcklund J; Carlsen S; Höger T; Holm B; Fugger L; Kihlberg J; Burkhardt H; Holmdahl R
Proc Natl Acad Sci U S A; 2002 Jul; 99(15):9960-5. PubMed ID: 12089323
[TBL] [Abstract][Full Text] [Related]
18. The DERAA HLA-DR alleles in patients with early polyarthritis: protection against severe disease and lack of association with rheumatoid arthritis autoantibodies.
Carrier N; Cossette P; Daniel C; de Brum-Fernandes A; Liang P; Ménard HA; Boire G
Arthritis Rheum; 2009 Mar; 60(3):698-707. PubMed ID: 19248090
[TBL] [Abstract][Full Text] [Related]
19. HLA-DRB1 genotype influences risk for and severity of rheumatoid arthritis.
Meyer JM; Evans TI; Small RE; Redford TW; Han J; Singh R; Moxley G
J Rheumatol; 1999 May; 26(5):1024-34. PubMed ID: 10332964
[TBL] [Abstract][Full Text] [Related]
20. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
